Annual Net Income
-$572.84 M
-$144.52 M-33.74%
December 31, 2022
Summary
- As of March 1, 2025, SRNE annual net profit is -$572.84 million, with the most recent change of -$144.52 million (-33.74%) on December 31, 2022.
- During the last 3 years, SRNE annual net income has fallen by -$280.77 million (-96.13%).
- SRNE annual net income is now -6372.92% below its all-time high of $9.13 million, reached on December 31, 2017.
Performance
SRNE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$95.21 M
+$44.40 M+31.80%
June 30, 2023
Summary
- As of March 1, 2025, SRNE quarterly net profit is -$95.21 million, with the most recent change of +$44.40 million (+31.80%) on June 30, 2023.
- Over the past year, SRNE quarterly net income has increased by +$44.40 million (+31.80%).
- SRNE quarterly net income is now -296.54% below its all-time high of $48.45 million, reached on December 31, 2017.
Performance
SRNE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$548.10 M
+$123.55 M+18.39%
June 30, 2023
Summary
- As of March 1, 2025, SRNE TTM net profit is -$548.10 million, with the most recent change of +$123.55 million (+18.39%) on June 30, 2023.
- Over the past year, SRNE TTM net income has increased by +$123.55 million (+18.39%).
- SRNE TTM net income is now -6101.27% below its all-time high of $9.13 million, reached on December 31, 2017.
Performance
SRNE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SRNE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.7% | +31.8% | +18.4% |
| 3 y3 years | -96.1% | +31.8% | +18.4% |
| 5 y5 years | -6372.9% | +31.8% | +18.4% |
SRNE Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.7% | at low | -133.3% | +57.4% | -28.0% | +18.4% |
| 5 y | 5-year | -96.1% | at low | -3893.3% | +57.4% | -137.5% | +18.4% |
| alltime | all time | -6372.9% | at low | -296.5% | +57.4% | -6101.3% | +18.4% |
Sorrento Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$95.21 M(-31.8%) | -$548.10 M(-18.4%) |
| Mar 2023 | - | -$139.62 M(-37.6%) | -$671.64 M(+17.2%) |
| Dec 2022 | -$572.84 M(+33.7%) | -$223.69 M(+149.7%) | -$572.84 M(+16.1%) |
| Sep 2022 | - | -$89.58 M(-59.1%) | -$493.57 M(-5.8%) |
| Jun 2022 | - | -$218.76 M(+436.0%) | -$523.79 M(+11.1%) |
| Mar 2022 | - | -$40.81 M(-71.7%) | -$471.65 M(+10.1%) |
| Dec 2021 | -$428.32 M(+43.5%) | -$144.42 M(+20.5%) | -$428.32 M(+20.5%) |
| Sep 2021 | - | -$119.80 M(-28.1%) | -$355.41 M(+11.2%) |
| Jun 2021 | - | -$166.62 M(-6738.0%) | -$319.63 M(+38.5%) |
| Mar 2021 | - | $2.51 M(-103.5%) | -$230.75 M(-22.7%) |
| Dec 2020 | -$298.46 M(+2.2%) | -$71.50 M(-14.9%) | -$298.46 M(+3.0%) |
| Sep 2020 | - | -$84.02 M(+8.1%) | -$289.78 M(+7.3%) |
| Jun 2020 | - | -$77.74 M(+19.2%) | -$270.17 M(+8.4%) |
| Mar 2020 | - | -$65.19 M(+3.8%) | -$249.19 M(-14.7%) |
| Dec 2019 | -$292.07 M(+43.5%) | -$62.82 M(-2.5%) | -$292.07 M(+4.7%) |
| Sep 2019 | - | -$64.42 M(+13.5%) | -$279.02 M(+6.5%) |
| Jun 2019 | - | -$56.76 M(-47.5%) | -$261.94 M(-6.1%) |
| Mar 2019 | - | -$108.07 M(+117.1%) | -$279.04 M(+37.1%) |
| Dec 2018 | -$203.54 M(-2328.9%) | -$49.78 M(+5.2%) | -$203.54 M(+93.3%) |
| Sep 2018 | - | -$47.33 M(-35.9%) | -$105.32 M(+75.4%) |
| Jun 2018 | - | -$73.86 M(+126.8%) | -$60.05 M(>+9900.0%) |
| Mar 2018 | - | -$32.57 M(-167.2%) | -$377.00 K(-104.1%) |
| Dec 2017 | $9.13 M(-115.0%) | $48.45 M(-2450.6%) | $9.13 M(-116.0%) |
| Sep 2017 | - | -$2.06 M(-85.5%) | -$57.17 M(+45.8%) |
| Jun 2017 | - | -$14.19 M(-38.5%) | -$39.22 M(-42.6%) |
| Mar 2017 | - | -$23.06 M(+29.2%) | -$68.34 M(+12.2%) |
| Dec 2016 | -$60.92 M(+33.0%) | -$17.86 M(-212.4%) | -$60.92 M(-8.4%) |
| Sep 2016 | - | $15.89 M(-136.7%) | -$66.54 M(-20.2%) |
| Jun 2016 | - | -$43.31 M(+176.7%) | -$83.37 M(+63.4%) |
| Mar 2016 | - | -$15.65 M(-33.3%) | -$51.02 M(+11.4%) |
| Dec 2015 | -$45.81 M(+32.2%) | -$23.48 M(+2400.1%) | -$45.81 M(+48.5%) |
| Sep 2015 | - | -$939.00 K(-91.4%) | -$30.84 M(-17.8%) |
| Jun 2015 | - | -$10.96 M(+5.0%) | -$37.51 M(+7.2%) |
| Mar 2015 | - | -$10.44 M(+22.7%) | -$35.00 M(+1.0%) |
| Dec 2014 | -$34.66 M | -$8.51 M(+11.8%) | -$34.66 M(-7.5%) |
| Sep 2014 | - | -$7.61 M(-10.0%) | -$37.45 M(+12.8%) |
| Jun 2014 | - | -$8.45 M(-16.2%) | -$33.20 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$10.09 M(-10.6%) | -$29.48 M(+34.6%) |
| Dec 2013 | -$21.91 M(+352.2%) | -$11.30 M(+236.6%) | -$21.91 M(+77.1%) |
| Sep 2013 | - | -$3.36 M(-29.2%) | -$12.37 M(+20.6%) |
| Jun 2013 | - | -$4.74 M(+87.8%) | -$10.25 M(+58.7%) |
| Mar 2013 | - | -$2.52 M(+43.7%) | -$6.46 M(+33.4%) |
| Dec 2012 | -$4.84 M(+49.7%) | -$1.75 M(+41.4%) | -$4.84 M(+25.8%) |
| Sep 2012 | - | -$1.24 M(+31.6%) | -$3.85 M(+16.3%) |
| Jun 2012 | - | -$943.10 K(+4.1%) | -$3.31 M(-4.2%) |
| Mar 2012 | - | -$906.10 K(+18.9%) | -$3.46 M(+6.9%) |
| Dec 2011 | -$3.24 M(+79.0%) | -$762.10 K(+8.5%) | -$3.24 M(+21.6%) |
| Sep 2011 | - | -$702.30 K(-35.4%) | -$2.66 M(+10.7%) |
| Jun 2011 | - | -$1.09 M(+58.9%) | -$2.40 M(+27.0%) |
| Mar 2011 | - | -$684.40 K(+263.8%) | -$1.89 M(+4.7%) |
| Dec 2010 | -$1.81 M(+91.9%) | -$188.10 K(-57.7%) | -$1.81 M(-21.6%) |
| Sep 2010 | - | -$444.80 K(-22.7%) | -$2.31 M(+10.2%) |
| Jun 2010 | - | -$575.60 K(-4.1%) | -$2.09 M(+35.7%) |
| Mar 2010 | - | -$599.90 K(-12.5%) | -$1.54 M(+63.7%) |
| Dec 2009 | -$942.30 K(+3566.5%) | -$685.90 K(+195.8%) | -$942.20 K(+581.3%) |
| Sep 2009 | - | -$231.90 K(+850.4%) | -$138.30 K(+337.7%) |
| Jun 2009 | - | -$24.40 K(-120.7%) | -$31.60 K(+22.5%) |
| Dec 2008 | -$25.70 K(-90.5%) | $118.00 K(-194.2%) | -$25.80 K(-82.9%) |
| Sep 2008 | - | -$125.20 K(+2218.5%) | -$151.20 K(+313.1%) |
| Jun 2008 | - | -$5400.00(-59.1%) | -$36.60 K(-16.4%) |
| Mar 2008 | - | -$13.20 K(+78.4%) | -$43.80 K(-83.8%) |
| Dec 2007 | -$270.60 K(-38.4%) | -$7400.00(-30.2%) | -$270.50 K(+2.8%) |
| Sep 2007 | - | -$10.60 K(-15.9%) | -$263.10 K(+4.2%) |
| Jun 2007 | - | -$12.60 K(-94.7%) | -$252.50 K(+5.3%) |
| Mar 2007 | - | -$239.90 K(-22.0%) | -$239.90 K(-22.1%) |
| Dec 2006 | -$439.30 K(+42.6%) | - | - |
| Dec 2005 | -$308.00 K(>+9900.0%) | -$307.50 K(>+9900.0%) | -$308.10 K(>+9900.0%) |
| Sep 2005 | - | -$200.00(0.0%) | -$800.00(0.0%) |
| Jun 2005 | - | -$200.00(0.0%) | -$800.00(0.0%) |
| Mar 2005 | - | -$200.00(0.0%) | -$800.00(0.0%) |
| Dec 2004 | -$800.00(0.0%) | -$200.00(0.0%) | -$800.00(+33.3%) |
| Sep 2004 | - | -$200.00(0.0%) | -$600.00(+50.0%) |
| Jun 2004 | - | -$200.00(0.0%) | -$400.00(+100.0%) |
| Mar 2004 | - | -$200.00 | -$200.00 |
| Dec 2003 | -$800.00 | - | - |
FAQ
- What is Sorrento Therapeutics annual net profit?
- What is the all time high annual net income for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual net income year-on-year change?
- What is Sorrento Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly net income year-on-year change?
- What is Sorrento Therapeutics TTM net profit?
- What is the all time high TTM net income for Sorrento Therapeutics?
- What is Sorrento Therapeutics TTM net income year-on-year change?
What is Sorrento Therapeutics annual net profit?
The current annual net income of SRNE is -$572.84 M
What is the all time high annual net income for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual net profit is $9.13 M
What is Sorrento Therapeutics annual net income year-on-year change?
Over the past year, SRNE annual net profit has changed by -$144.52 M (-33.74%)
What is Sorrento Therapeutics quarterly net profit?
The current quarterly net income of SRNE is -$95.21 M
What is the all time high quarterly net income for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly net profit is $48.45 M
What is Sorrento Therapeutics quarterly net income year-on-year change?
Over the past year, SRNE quarterly net profit has changed by +$44.40 M (+31.80%)
What is Sorrento Therapeutics TTM net profit?
The current TTM net income of SRNE is -$548.10 M
What is the all time high TTM net income for Sorrento Therapeutics?
Sorrento Therapeutics all-time high TTM net profit is $9.13 M
What is Sorrento Therapeutics TTM net income year-on-year change?
Over the past year, SRNE TTM net profit has changed by +$123.55 M (+18.39%)